Jagsonpal Pharmaceuticals Limited

₹217.39As of Sun 8 Nov 2026, 12:00 UTC
NSE:JAGSNPHARMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 30.56%
Div yield 1.15%
ROE 18.18%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.26)
PE TTM 32.61
TSR TTM (0.81%)
Mkt cap ₹14.36B
ROIC 24.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹229
5.30%
(64.11%)
Hold 2|10|9|0|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.86
3.96
3.79
4.17
33.48%
32.72%
20.11%
20.49%
Revenue₹B
1.228
1.254
1.228
1.197
17.81%
14.52%
8.28%
3.23%
Peers (US$149.8M)
Cap (US$)
PE
194.9M
40.75x
152.8M
31.51x
Capital
TTM
5Y
10Y
Leveragex
1.344
0.170
0.162
EBIT/Intx
0.081
0.726
0.655
Own earn%
28.75
(6.87)
(7.86)
Sh yield%
18.06
13.48
11.40
Owners
Insiders/Inst%
10.59
74.40
Short interest%
2.48
SBC / revenue%
4.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
19–26
$1 testx
—
Incr. ROIC%
2